1. Home
  2. ADMA vs HESM Comparison

ADMA vs HESM Comparison

Compare ADMA & HESM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • HESM
  • Stock Information
  • Founded
  • ADMA 2004
  • HESM 2014
  • Country
  • ADMA United States
  • HESM United States
  • Employees
  • ADMA N/A
  • HESM N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • HESM Oil & Gas Production
  • Sector
  • ADMA Health Care
  • HESM Energy
  • Exchange
  • ADMA Nasdaq
  • HESM Nasdaq
  • Market Cap
  • ADMA 4.1B
  • HESM 4.7B
  • IPO Year
  • ADMA N/A
  • HESM N/A
  • Fundamental
  • Price
  • ADMA $17.91
  • HESM $40.70
  • Analyst Decision
  • ADMA Strong Buy
  • HESM Buy
  • Analyst Count
  • ADMA 4
  • HESM 5
  • Target Price
  • ADMA $22.50
  • HESM $42.60
  • AVG Volume (30 Days)
  • ADMA 2.7M
  • HESM 1.3M
  • Earning Date
  • ADMA 03-03-2025
  • HESM 04-24-2025
  • Dividend Yield
  • ADMA N/A
  • HESM 6.65%
  • EPS Growth
  • ADMA N/A
  • HESM 19.71
  • EPS
  • ADMA 0.81
  • HESM 2.49
  • Revenue
  • ADMA $426,454,000.00
  • HESM $1,495,500,000.00
  • Revenue This Year
  • ADMA $16.18
  • HESM $12.94
  • Revenue Next Year
  • ADMA $23.92
  • HESM $10.66
  • P/E Ratio
  • ADMA $22.12
  • HESM $16.35
  • Revenue Growth
  • ADMA 65.15
  • HESM 10.89
  • 52 Week Low
  • ADMA $5.88
  • HESM $32.75
  • 52 Week High
  • ADMA $23.64
  • HESM $42.31
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 58.84
  • HESM 52.48
  • Support Level
  • ADMA $15.88
  • HESM $39.06
  • Resistance Level
  • ADMA $18.25
  • HESM $41.26
  • Average True Range (ATR)
  • ADMA 1.12
  • HESM 1.10
  • MACD
  • ADMA 0.25
  • HESM -0.06
  • Stochastic Oscillator
  • ADMA 86.13
  • HESM 50.46

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About HESM Hess Midstream LP Share

Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.

Share on Social Networks: